Macro
·
Dawson Ignatieff
·
Apr 2024
3
min read
Find the latest industry news and articles
$ATAI is developing fast-acting, patent-protected psychedelic treatments for depression, with strong clinical results and billion-dollar M&A comps. Backed by Bitcoin and biotech tailwinds, it’s a high-upside asymmetric play.